🇺🇸
United States · US · US:0169-2662_e5571110-ca7e-4fcc-88a8-9f1d0104c508
Tresiba
In shortageUNIISPLATC A10AE06
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerNovo Nordisk
CountryUS (United States)
ATC codeA10AE06
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 2
- ndc1101692662111 VIAL, GLASS in 1 CARTON (0169-2662-11) / 10 mL in 1 VIAL, GLASS
- ndc1101692662901 VIAL, GLASS in 1 CARTON (0169-2662-90) / 10 mL in 1 VIAL, GLASS
Annotations
UNII (FDA Substance ID)
54Q18076QB
INSULIN DEGLUDEC
RxCUI 1670007
DailyMed SPL labels
1 version tracked
FDA shortage
Currently in shortage
Insulin Aspart Injection
Raw payload (JSON)
{
"unii": {
"unii": "54Q18076QB",
"rxcui": "1670007",
"inchikey": null,
"display_name": "INSULIN DEGLUDEC",
"substance_type": "protein",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "SUBCUTANEOUS",
"spl_meta": {
"e8ccd2f4-6ba9-4839-87f8-4742dc9b1c17": {
"match": "brand_token",
"title": "TRESIBA (INSULIN DEGLUDEC) INJECTION, SOLUTION [A-S MEDICATION SOLUTIONS]",
"spl_version": "1",
"published_date": "2024-02-27"
}
},
"productid": "0169-2662_e5571110-ca7e-4fcc-88a8-9f1d0104c508",
"productndc": "0169-2662",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "INSULIN DEGLUDEC",
"shortage_reason": "Insulin Aspart Injection",
"shortage_status": "current",
"proprietary_name": "Tresiba",
"active_ingred_unit": "U/mL",
"application_number": "BLA203314",
"marketing_category": "BLA",
"nonproprietary_name": "insulin degludec",
"start_marketing_date": "20181121",
"active_numerator_strength": "100"
}Related drugs
Other records sharing ATC code A10AE06.
Access this data programmatically
Query Tresiba and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.